DESITIN PHARMA A/S: Financial statements 2015
CVR: 19389006
Source: annual report 2015, Danish Business Authority
01/10/2014 – 30/09/2015
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 7,412,331 and a net result of DKK 2,362,269 compared with EUR 287,303 the year before. That is an increase of 674.1% compared with the year before. Equity in the 2015 report amounted to DKK 3,683,876. The solvency ratio was 67.9%.
- Gross Profit
- DKK 7,412,331
- Profit/Loss
- DKK 2,362,269
- Equity
- DKK 3,683,876
- Total Assets
- DKK 5,427,894
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 7.4 mio. | 2.4 mio. | 3.7 mio. | - |
| 2014 | - | 958 t. EUR | 287 t. EUR | 379 t. EUR | - |
| 2013 | - | 881 t. EUR | 209 t. EUR | 342 t. EUR | - |
Official annual report
How creditworthy is DESITIN PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
DESITIN PHARMA A/S has published its annual report for 2014. Gross profit came to DKK 957,551, and the net result was DKK 287,303.
About DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,151,761 and a net result of DKK 288,733 compared with DKK 285,567 the year before. Equity in the 2025 report amounted to DKK 7,044,140.